Christophe Parent

Christophe Parent is the Executive Director of Finance at Gilead Sciences, with over 25 years of experience in the pharmaceutical industry. Previously, they served in various finance leadership roles at Sanofi Synthelabo, Sanofi Aventis, and Ipsen, including positions as Financial Director for the Middle East and Russia and Vice President of Financial Planning and Analysis. Christophe holds a Master of Business Administration from ISG Institut Supérieur de Gestion, awarded in 1993. They have a strong international background and a proven track record in business partnering, profitability improvement, and purchasing strategies.